ImmuOne
The company provides in vitro human airway models and contract research services for inhalation toxicology and drug development. Its patented products, ImmuPHAGE and ImmuLUNG, utilize alveolar macrophages to assess immune responses to inhaled chemicals and particulates. These solutions serve the pharmaceutical and chemical industries by providing human-relevant safety data while reducing reliance on animal testing.
Visit websiteLondon, UK
Healthtech
Biotechnology
Life Sciences
Drug Discovery
Funding summary
- Total raised
- €2.9M
- Funding rounds
- 2
Investors in ImmuOne
Investors on record for ImmuOne. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like ImmuOne?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors